Creator: Help Dementia Editorial Team
Published: 2026-05-23T01:53:23

Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.

Try sudafed sits at the center of this dementia and brain health question.

No, you should not try Sudafed PE for snoring from a cold. Despite being widely available over the counter, the FDA has determined that oral phenylephrine—the active ingredient in Sudafed PE—is not actually effective at relieving nasal congestion. In November 2024, the FDA issued a proposed order to remove oral phenylephrine products from the market, concluding that large clinical trials have shown the medication performs no better than a placebo at standard dosages.

If you or a loved one has been using Sudafed PE tablets hoping to clear nighttime congestion and reduce snoring, it’s worth understanding what the evidence really shows and what better options might exist. The reality is that many people have been relying on a medication that decades of scientific evidence suggest doesn’t work. While the FDA’s move to remove phenylephrine isn’t based on safety concerns—the drug isn’t dangerous—it highlights an important gap between what consumers believe about over-the-counter medications and what clinical research actually demonstrates. For those managing cold-related snoring, particularly caregivers concerned about sleep disruption for themselves or others in their care, knowing the facts about Sudafed PE can help you make better choices.

Does Sudafed PE Actually Work for Cold-Related Nasal Congestion?
What the FDA Found About Oral Phenylephrine and Why It Matters
Why Cold-Related Snoring Makes People Reach for Quick Fixes
Better Alternatives to Sudafed PE for Nasal Congestion and Snoring
Side Effects and Why You Want to Avoid Unnecessary Medications
The Important Distinction Between Oral and Nasal Spray Phenylephrine
What’s Ahead for Sudafed PE and Cold Medications
Conclusion

The short answer is no, not according to the most rigorous clinical evidence. While Sudafed PE has been available for years and marketed as a decongestant, an FDA advisory committee unanimously voted in September 2023 that oral phenylephrine is not “Generally Recognized As Safe and Effective” (GRASE). This unanimous decision was historic—it doesn’t happen often that an entire advisory panel agrees on something. The committee reviewed decades of research, including large clinical trials conducted since 2007, and found that phenylephrine taken as a pill or tablet fails to provide meaningful relief from nasal congestion at the doses people typically take. What makes this finding especially significant is the contrast with what the FDA concluded in 2007. Back then, an advisory panel said phenylephrine “may be effective,” which was enough for the drug to remain on store shelves.

However, the subsequent large clinical trials have fundamentally changed the picture. These studies have repeatedly shown that oral phenylephrine performs no differently than a placebo—meaning that if you take Sudafed PE, you’re likely getting the same relief as you would from a sugar pill. For someone hoping that clearing nasal congestion will reduce snoring during a cold, this is a critical limitation. The evidence on phenylephrine’s effectiveness is now so clear that regulatory action followed. In November 2024, the FDA formally proposed removing oral phenylephrine from the market entirely. The agency set a public comment period that closed in May 2025, and if the removal is finalized, it would take effect no sooner than the second half of 2026. This process itself reflects how serious the FDA’s concerns about ineffectiveness have become.

Does Sudafed PE Actually Work for Cold-Related Nasal Congestion?

What the FDA Found About Oral Phenylephrine and Why It Matters

The FDA’s decision to propose removing phenylephrine wasn’t made lightly or quickly. The agency has been reviewing this ingredient for years, watching as clinical evidence accumulated showing it doesn’t work. The key finding is that phenylephrine is not systemically available—meaning when you take it orally, your body either doesn’t absorb it properly or processes it in ways that make it ineffective for nasal decongestant purposes. This is a pharmacological limitation, not a flaw in how people use the drug. What’s particularly striking is that this same ingredient works fine in nasal spray formulations.

The FDA’s concerns apply only to oral phenylephrine (pills, tablets, and capsules), not to phenylephrine nasal sprays. This distinction is important because it shows the problem isn’t with phenylephrine itself, but with how the body handles it when taken by mouth. If you’ve used Sudafed PE tablets thinking they’re helping your cold symptoms, the science suggests that any relief you experienced was likely due to other factors—the placebo effect, the passage of time, or the benefits of other ingredients in your cold medication. The limitation of oral phenylephrine means that people who have relied on it for years may need to reconsider their approach to treating nasal congestion. For those managing snoring related to a cold, this is particularly relevant because nasal congestion is often a key driver of snoring, and an ineffective treatment leaves you back at square one.

Cold-related snoring is frustrating for everyone involved. When you or someone in your care has nasal congestion from a cold, sleep quality suffers dramatically. The snoring itself disrupts sleep, and the congestion makes it difficult to breathe comfortably. This creates a real problem: someone lies in bed unable to breathe through their nose, mouth-breathing uncomfortably, and snoring loudly enough to wake others in the household. It’s understandable why someone would grab an over-the-counter decongestant like Sudafed PE, hoping for quick relief. The appeal of Sudafed PE is that it’s accessible, inexpensive, and socially normalized.

Millions of people take it, and it’s been marketed for decades as a reliable cold remedy. If you see it on store shelves next to other trusted medications, it’s reasonable to assume it works. The packaging promises relief, and the price is right. For caregivers particularly—perhaps managing the sleep disruption caused by a family member’s cold-related snoring—the convenience of grabbing a package from the pharmacy feels like a sensible solution. However, the reality is that this apparent solution doesn’t actually deliver what the package promises. This makes it even more important to understand what will actually help when you’re dealing with cold-related congestion and snoring.

Why Cold-Related Snoring Makes People Reach for Quick Fixes

Better Alternatives to Sudafed PE for Nasal Congestion and Snoring

If Sudafed PE doesn’t work, what should you use instead? Nasal saline rinses or sprays are among the most evidence-based approaches. Saline solutions help clear mucus and congestion without relying on decongestant medications, and they’re safe for extended use. For many people, a simple saline rinse using a neti pot or saline spray before bed can significantly improve nighttime breathing and reduce snoring during a cold. Nasal sprays containing phenylephrine (yes, the same ingredient, but in a different form) actually do work when applied directly to the nasal passages. Because the medication contacts the tissue directly, it bypasses the absorption problems that make oral phenylephrine ineffective.

Other decongestant options include pseudoephedrine, which requires showing ID to purchase and is kept behind the pharmacy counter, but it does have clinical evidence supporting its effectiveness at relieving congestion—a key difference from Sudafed PE. Pseudoephedrine can have side effects like increased heart rate and nervousness, so it’s not right for everyone, particularly older adults or those with certain health conditions. Another practical approach is to address the snoring more directly through non-medication strategies: elevating the head of the bed, using humidified air, and trying nasal strips that mechanically open the nasal passages. These methods have no systemic side effects and often provide meaningful relief. For someone managing a cold during sleep, even simple comfort measures like keeping the bedroom warm and humid can help.

Side Effects and Why You Want to Avoid Unnecessary Medications

While Sudafed PE’s main problem is that it doesn’t work, it’s worth knowing that people who take it often experience side effects. Common adverse effects include nervousness, dizziness, and sleeplessness. For someone already struggling with poor sleep due to cold-related nasal congestion, adding a medication that causes sleeplessness is particularly counterproductive. You’re essentially trading one sleep problem (congestion-related snoring) for another (drug-induced insomnia).

This is a critical limitation for caregivers or older adults concerned about medication side effects. If someone in your care has heart palpitations, anxiety, or is already taking medications that affect the nervous system, the nervousness and dizziness from Sudafed PE become even more problematic. The fact that the medication doesn’t work makes these side effects particularly difficult to justify. Why tolerate dizziness or insomnia for a treatment that offers no meaningful benefit over a placebo? The warning here is straightforward: don’t take medication expecting side effects when the medication itself doesn’t provide the benefit you’re seeking. The risk-to-benefit calculation falls apart when the “benefit” is essentially nonexistent.

Side Effects and Why You Want to Avoid Unnecessary Medications

The Important Distinction Between Oral and Nasal Spray Phenylephrine

One critical point that often gets lost in discussions about phenylephrine is that the FDA’s concerns apply only to oral forms of the drug. If you use a nasal spray containing phenylephrine, the FDA is not proposing to remove it from the market. This is an important distinction because it reflects a real pharmacological difference—nasal spray works, tablets don’t.

When phenylephrine is applied directly to nasal tissue as a spray, it contacts the area where it’s needed and can provide meaningful decongestant effects. This is why phenylephrine nasal sprays remain a viable option even as the FDA moves to remove oral phenylephrine. If you’ve had success using a phenylephrine nasal spray during a cold, that’s not contradicting the FDA’s findings—the spray formulation is genuinely different and more effective. Just make sure not to overuse nasal decongestant sprays, as prolonged use can lead to rebound congestion, where your nasal passages become even more congested when you stop using the spray.

What’s Ahead for Sudafed PE and Cold Medications

The FDA’s proposed removal of oral phenylephrine marks a turning point in how we think about common cold medications. The process won’t be instantaneous—if finalized, removal would become effective no sooner than the second half of 2026. This timeline gives manufacturers and consumers time to adjust, but it also means that for the next year or so, you’ll still see Sudafed PE on store shelves despite the FDA’s conclusion that it doesn’t work.

Looking forward, this decision may prompt a broader reassessment of other over-the-counter cold medications. Are there other ingredients that have been on the market for years despite limited evidence of effectiveness? The phenylephrine case suggests that regulatory agencies are taking a closer look at this question. For consumers and caregivers, the takeaway is to look beyond brand recognition and marketing when choosing remedies for cold symptoms. The most heavily advertised option isn’t always the most effective, and sometimes the oldest remedies—like saline rinses and humidified air—have evidence supporting them that newer, fancier products simply don’t.

Conclusion

Should you try Sudafed PE for snoring from a cold? No. The medication has no meaningful effect on nasal congestion beyond placebo, according to the FDA and decades of clinical research. It may cause side effects like nervousness and dizziness without providing the relief you need, making it an inefficient use of medication.

The FDA’s 2024 proposal to remove it from the market reflects a long overdue recognition that a medication trusted by millions simply doesn’t work. Instead, focus on evidence-based alternatives: saline rinses, nasal sprays that actually work (including phenylephrine nasal sprays, which are different from oral tablets), or simple comfort measures like humidified air and elevated sleep positions. If you’re managing cold-related snoring for yourself or someone in your care, choosing a treatment that actually works will serve you far better than reaching for a familiar package that makes empty promises. When the FDA removes Sudafed PE from shelves in the coming months, it will be removing a product that patients and caregivers would have been better served avoiding all along.